NXGL insider buying and SEC filings, explained
Nexgel, Inc. · CIK 1468929
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq, Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- NEXGEL, INC.; AquaMed Technologies, Inc.
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$37K
Planned sales (10b5-1)
$10K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 18–23, 2026 | Sale | Adam R. Levy (CEO and Director) sold 11,000 shares between Jun 18 and Jun 23 at about $0.5900 ($6K). Holdings down 3% to 322,692 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 23, 2026 |
| Jun 11, 2026 | Sale | Adam R. Levy (CEO and Director) sold 3,000 shares at $0.6100 ($2K). Holdings down 1% to 333,692 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 4–8, 2026 | Sale | Adam R. Levy (CEO and Director) sold 6,000 shares between Jun 4 and Jun 8 at about $0.5700 ($3K). Holdings down 2% to 336,692 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 9, 2026 |
| Jun 1, 2026 | Sale | Adam R. Levy (CEO and Director) sold 2,000 shares at $0.5900 ($1K). Holdings down 1% to 342,692 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| May 27–29, 2026 | Sale | Adam R. Levy (CEO and Director) sold 13,000 shares between May 27 and May 29 at about $0.6054 ($8K). Holdings down 4% to 344,692 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 29, 2026 |
| May 14, 2026 | Other purchase | Scott Robert Henry (Director) bought 62,501 Convertible Promissory Note (the "Note") in 2 share classes at about $0.4000 ($25K), reported as a purchase (code P). New position of 41,667 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| May 14, 2026 | Other purchase | Adam R. Levy (CEO and Director) bought 150,000 Convertible Promissory Note (the "Note") in 2 share classes at about $0.4000 ($60K), reported as a purchase (code P). New position of 100,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| May 11, 2026 | Other purchase | Brian Joseph Kieser (Director) bought 2,500,001 Convertible Promissory Note (the "Note") in 2 share classes at about $0.4000 ($1.0M), reported as a purchase (code P). New position of 1,666,667 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| Dec 22–24, 2025 | Sale | Adam R. Levy (CEO and Director) sold 10,000 shares between Dec 22, 2025 and Dec 24, 2025 at about $1.59 ($16K). Holdings down 3% to 357,692 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 29, 2025 |
| Nov 6, 2025 | Planned (10b5-1) | Adam R. Levy (CEO and Director) sold 4,000 shares at about $2.52 ($10K), marked as a 10b5-1 plan trade. Holdings down 1% to 367,692 shares. | SEC filing Filed Nov 7, 2025 |
1 routine transaction (such as a grant, option exercise or tax withholding) is not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow NXGL in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.